You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Diabetic Nephropathy

Showing 1 - 25 of 7,396
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urinary Exosome in Type 2 Diabetic Nephropathy and Evaluation of

Active, not recruiting
  • Diabetic Nephropathy
  • Grouping based on previous laboratory results, no intervention.
  • Jinan, Shandong, China
    Qianfoshan Hospital
Oct 24, 2023

Diabetic Nephropathies Trial (Henagliflozin, Placebo)

Not yet recruiting
  • Diabetic Nephropathies
  • (no location specified)
Sep 3, 2023

Type 1 Diabetic Nephropathy Trial in Cairo (oral sitagliptin supplementation)

Completed
  • Type 1 Diabetic Nephropathy
  • oral sitagliptin supplementation
  • Cairo, Egypt
    Nancy Elbarbary
Nov 2, 2023

CRP to Serum Albumin Ratio in Type 2 DM é Diabetic Nephropathy

Not yet recruiting
  • Type 2 DM /Diabetic Nephropathy
    • (no location specified)
    Jan 28, 2023

    Diabetic Nephropathy Type 2 Trial (Acetylsalicylic Acid, Placebo)

    Not yet recruiting
    • Diabetic Nephropathy Type 2
    • Acetylsalicylic Acid
    • Placebo
    • (no location specified)
    Sep 28, 2023

    Urinary Exosome in Type 2 Diabetic Kidney Disease and Evaluation

    Active, not recruiting
    • Diabetic Nephropathy
    • Grouping based on previous laboratory results, no intervention.
    • Jinan, Shandong, China
      Qianfoshan Hospital
    Nov 8, 2023

    Diabetic Kidney Disease Trial in Herlev (ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide,

    Recruiting
    • Diabetic Kidney Disease
    • ACEi / ARB, SGLT2i, finerenone, semaglutide, pentoxifylline, hydrochlorthiazide, baricitinib
    • Herlev, Denmark
      Department of Nephrology, Herlev and Gentofte Hospital
    May 31, 2023

    Diabetes, Type 1 Trial in Cairo (oral omega-3 fatty acids supplementation, Placebo)

    Completed
    • Diabetes Mellitus, Type 1
    • oral omega-3 fatty acids supplementation
    • Placebo
    • Cairo, Egypt
      Nancy Elbarbary
    Aug 4, 2023

    Triglyceride-Glucose Index in Diabetic Nephropathy in Type

    Not yet recruiting
    • Diabetes Mellitus, Type 2
      • (no location specified)
      Oct 28, 2022

      Urinary Uromodulin and Corresponding Urinary Exosomal UMOD mRNA

      Completed
      • Diabetic Nephropathy, Urinary Uromodulin, Exosomal UMOD mRNA Gene Expression
      • ACR, fasting, postprandial blood glucose ,HbA1c, creatinine, cystatin-C, BUN, Na, K , lipid profile
      • Tanta, Al Gharbia, Egypt
        Tanta university hospital, faculty of science, tanta university
      Jan 24, 2023

      Diabetic Nephropathy Type 2 Trial (Tadalafil 20Mg Oral Tablet, Pentoxifylline 400 MG Oral Tablet)

      Not yet recruiting
      • Diabetic Nephropathy Type 2
      • Tadalafil 20Mg Oral Tablet
      • Pentoxifylline 400 MG Oral Tablet
      • (no location specified)
      Aug 2, 2022

      Sub-optimal Vitamin D Status, Bone Disease, Diabetic Nephropathy Trial in Edmonton (Vitamin D3)

      Completed
      • Sub-optimal Vitamin D Status
      • +2 more
      • Vitamin D3
      • Edmonton, Alberta, Canada
        Clinical Research Unit, University of Alberta
      Aug 25, 2022

      Technology and Clinical Transformation of Type 2 Diabetes

      Recruiting
      • Diabetic Nephropathy Type 2
      • +2 more
        • Beijing, China
          Chinese PLA General Hospital
        May 25, 2023

        Diabetic Nephropathy Trial in Nice (telmisartan during 6 months, Losartan during 6 months, blood sample)

        Completed
        • Diabetic Nephropathy
        • telmisartan during 6 months
        • +2 more
        • Nice, France
          CHU de Nice
        May 13, 2022

        Diabetic Nephropathies Trial in Dalian (Huangqi Guizhi Wuwu decoction, Dapagliflozin)

        Recruiting
        • Diabetic Nephropathies
        • Dalian, Liaoning, China
          The First Affiliated Hospital of Dalian medical university
        Jun 10, 2022

        Diabetic Nephropathies Trial in Tanta (Niclosamide, Placebo oral tablet)

        Completed
        • Diabetic Nephropathies
        • Tanta, Egypt
          Faculty of Pharmacy, Tanta University
        Oct 19, 2022

        Diabetic Nephropathy in Qatari Population

        Completed
        • Type 2 Diabetes
          • Doha, Qatar
            Hamad Medical Corporation
          Apr 29, 2022

          Through Transcriptomics

          Active, not recruiting
          • Type 2 Diabetes
          • Type 2 Diabetes With Renal Manifestations
            • Mexico City, Mexico
              Hospital Juárez de México
            May 12, 2022

            Diabetic Nephropathies Trial (Trimetazidine)

            Not yet recruiting
            • Diabetic Nephropathies
            • (no location specified)
            Nov 24, 2021

            Transplant Complication, Diabetic Nephropathy, Perioperative/Postoperative Complications Trial in Guangzhou (Enhanced recovery

            Completed
            • Transplant Complication
            • +2 more
            • Enhanced recovery for SPK recipients
            • Guangzhou, Guangdong, China
              Second affiliated hospital of Guangzhou Medical University
            Oct 18, 2023

            Diabetic Nephropathies Trial in Daegu (CU01-1001, Placebo)

            Recruiting
            • Diabetic Nephropathies
            • Daegu, Korea, Republic of
              Yeongnam University Medical Center
            Feb 6, 2023

            Irisin And Diabetic Nephropathy

            Not yet recruiting
            • Irisin
            • Laboratory tests
            • +5 more
            • (no location specified)
            Nov 20, 2021

            Diabetic Nephropathy Trial in Worldwide (Nidufexor, Placebo, Standard of Care (SoC))

            Completed
            Has Results
            • Diabetic Nephropathy
            • Miami Lakes, Florida
            • +17 more
            Aug 8, 2022

            circANKRD36 as a New Biomarker of Diabetic Nephropathy

            Not yet recruiting
            • Diabetic Nephropathy
            • circANKRD36 as a new biomarker
            • (no location specified)
            Sep 28, 2021

            SWIDINEP a Swiss Diabetic Nephropathy Cohort

            Active, not recruiting
            • Diabetic Nephropathy
              • Lausanne, Vaud, Switzerland
                Centre Hospitalier Universitaire Vaudois
              Aug 4, 2021